154 related articles for article (PubMed ID: 33965959)
1. The Influence of Endogenous Testosterone on Incidental Prostate Cancer after Transurethral Prostate Resection.
Porcaro AB; Siracusano S; Amigoni N; Tafuri A; Rizzetto R; Shakir A; Tiso L; Cerrato C; De Michele M; Bianchi A; Gallina S; Brunelli M; Migliorini F; Artibani W; Antonelli A
Urol Int; 2021; 105(9-10):826-834. PubMed ID: 33965959
[TBL] [Abstract][Full Text] [Related]
2. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
[TBL] [Abstract][Full Text] [Related]
3. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation.
Porreca A; D'Agostino D; Vigo M; Corsi P; Romagnoli D; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Giampaoli M
Arch Ital Urol Androl; 2020 Jan; 91(4):224-229. PubMed ID: 31937084
[TBL] [Abstract][Full Text] [Related]
4. A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection.
Wu Y; Pan H; Wang WM; Xu D; Zhang L; Gu ZQ; Bai Q; Qi J; Huang HF
Asian J Androl; 2017; 19(2):230-233. PubMed ID: 26763548
[TBL] [Abstract][Full Text] [Related]
5. Incidental prostate cancer after transurethral resection of the prostate: analysis of incidence and risk factors in 458 patients.
Porcaro AB; Tafuri A; Inverardi D; Amigoni N; Sebben M; Pirozzi M; Processali T; Rizzetto R; Shakir A; Cerrato C; Tiso L; Panunzio A; DE Michele M; Brunelli M; Siracusano S; Artibani W
Minerva Urol Nephrol; 2021 Aug; 73(4):471-480. PubMed ID: 32003204
[TBL] [Abstract][Full Text] [Related]
6. The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates.
Magistro G; Keller P; Westhofen T; Schott M; Tamalunas A; Weinhold P; Stief CG
World J Urol; 2021 May; 39(5):1481-1487. PubMed ID: 32588205
[TBL] [Abstract][Full Text] [Related]
7. The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?
Köllermann J; Hoeh B; Ruppel D; Smith K; Reis H; Wenzel M; Preisser F; Kosiba M; Mandel P; Karakiewicz PI; Becker A; Chun FKH; Wild P; Kluth LA
Virchows Arch; 2022 Sep; 481(3):387-396. PubMed ID: 35710851
[TBL] [Abstract][Full Text] [Related]
8. Is the systematic histological analysis of benign prostatic hyperplasia surgical specimen always necessary?
Coman R; Anract J; Pinar U; Sibony M; Peyromaure M; Delongchamps B
Int Urol Nephrol; 2022 Jul; 54(7):1485-1489. PubMed ID: 35536389
[TBL] [Abstract][Full Text] [Related]
9. Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?
Tonyali S; Ceylan C; Aglamis E; Dogan S; Tastemur S; Karaaslan M
Arch Ital Urol Androl; 2021 Mar; 93(1):31-34. PubMed ID: 33754606
[TBL] [Abstract][Full Text] [Related]
10. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
[TBL] [Abstract][Full Text] [Related]
11. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Ma W; Zeng G; Qi D
J Surg Oncol; 2011 Nov; 104(6):672-8. PubMed ID: 21674503
[TBL] [Abstract][Full Text] [Related]
12. Endogenous testosterone as a predictor of prostate growing disorders in the aging male.
Porcaro AB; Amigoni N; Tafuri A; Rizzetto R; Shakir A; Tiso L; Cerrato C; Lacola V; Antoniolli SZ; Gozzo A; Odorizzi K; Brunelli M; Migliorini F; Artibani W; Cerruto MA; Siracusano S; Antonelli A
Int Urol Nephrol; 2021 May; 53(5):843-854. PubMed ID: 33389506
[TBL] [Abstract][Full Text] [Related]
13. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
[TBL] [Abstract][Full Text] [Related]
14. Positive Association between Basal Total Testosterone Circulating Levels and Tumor Grade Groups at the Time of Diagnosis of Prostate Cancer.
Porcaro AB; Tafuri A; Sebben M; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Shakir A; Tiso L; Cerrato C; Panunzio A; De Michele M; Cerruto MA; Brunelli M; Migliorini F; Siracusano S; Artibani W
Urol Int; 2019; 103(4):400-407. PubMed ID: 31163438
[TBL] [Abstract][Full Text] [Related]
15. HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis.
Rosenhammer B; Lausenmeyer EM; Mayr R; Burger M; Eichelberg C
World J Urol; 2018 Dec; 36(12):2035-2041. PubMed ID: 29858700
[TBL] [Abstract][Full Text] [Related]
16. Does mechanical morcellation of large glands compromise incidental prostate cancer detection on specimen analysis? A pathological comparison with open simple prostatectomy.
Misraï V; Kerever S; Pasquie M; Bordier B; Guillotreau J; Palasse J; Guillotreau V; Rijo E; Vincendeau S; Huet R; Mathieu R; Peyronnet B; Rioux-Leclercq N; Compérat EM
World J Urol; 2019 Jul; 37(7):1315-1320. PubMed ID: 30350017
[TBL] [Abstract][Full Text] [Related]
17. Incidental finding of prostate cancer in Transurethral Resection of Prostate (TURP) specimens: a retrospective analysis from a Tertiary Care Hospital in Pakistan.
Janjua TK; Yousuf MA; Iqbal MT; Memon SM; Abdullah A; Faridi N; Irfan M
Pan Afr Med J; 2021; 39():20. PubMed ID: 34394811
[TBL] [Abstract][Full Text] [Related]
18. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
[TBL] [Abstract][Full Text] [Related]
19. Incidence and associated factors for incidental prostate cancer among patients who underwent surgery for benign prostatic hyperplasia: first report from Somalia.
Mohamed AH; Abdullahi IM; Warsame FF; Mohamud HA
J Cancer Res Clin Oncol; 2023 Jul; 149(7):4041-4046. PubMed ID: 36036824
[TBL] [Abstract][Full Text] [Related]
20. Do baseline estrogen and testosterone affect lower urinary tract symptoms (LUTS) prior to or after pharmacologic treatment with tadalafil?
Egan KB; Miner MM; Suh M; McVary K; Ni X; Roehrborn CG; Wittert G; Wong DG; Rosen RC
Andrology; 2015 Nov; 3(6):1165-72. PubMed ID: 26452447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
